Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 28;16(1):149.
doi: 10.3390/cancers16010149.

National Burden and Trends for 29 Groups of Cancer in Mexico from 1990 to 2019: A Secondary Analysis of the Global Burden of Disease Study 2019

Saul A Beltran-Ontiveros  1 , Jose A Contreras-Gutierrez  1 , Erik Lizarraga-Verdugo  1 , Erick P Gutierrez-Grijalva  2 , Kenia Lopez-Lopez  3 , Emilio H Lora-Fierro  1 , Miguel A Trujillo-Rojas  4 , Jose M Moreno-Ortiz  4 , Diana L Cardoso-Angulo  1 , Emir Leal-Leon  5 , Jose R Zatarain-Lopez  1 , Hector M Cuen-Diaz  1 , Marisol Montoya-Moreno  1 , Brisceyda Arce-Bojorquez  1 , Juan L Rochin-Teran  1 , Daniel E Cuen-Lazcano  1 , Victor A Contreras-Rodriguez  6 , Ricardo Lascurain  7 , Liliana Carmona-Aparicio  8 , Elvia Coballase-Urrutia  8 , Francisco Gallardo-Vera  9 , Daniel Diaz  10
Affiliations

National Burden and Trends for 29 Groups of Cancer in Mexico from 1990 to 2019: A Secondary Analysis of the Global Burden of Disease Study 2019

Saul A Beltran-Ontiveros et al. Cancers (Basel). .

Abstract

The global burden of cancer is on the rise, with varying national patterns. To gain a better understanding and control of cancer, it is essential to provide national estimates. Therefore, we present a comparative description of cancer incidence and mortality rates in Mexico from 1990 to 2019, by age and sex for 29 different cancer groups. Based on public data from the Global Burden of Disease Study 2019, we evaluated the national burden of cancer by analyzing counts and crude and age-standardized rates per 100,000 people with 95% uncertainty intervals for 2019 and trends using the annual percentage change from 1990 to 2019. In 2019, cancer resulted in 222,060 incident cases and 105,591 deaths. In 2019, the highest incidence of cancer was observed in non-melanoma skin cancer, prostate cancer, and breast cancer. Additionally, 53% of deaths were attributed to six cancer groups (lung, colorectal, stomach, prostate, breast, and pancreatic). From 1990 to 2019, there was an increasing trend in incidence and mortality rates, which varied by 10-436% among cancer groups. Furthermore, there were cancer-specific sex differences in crude and age-standardized rates. The results show an increase in the national cancer burden with sex-specific patterns of change. These findings can guide national efforts to reduce health loss due to cancer.

Keywords: burden of disease; cancer epidemiology; cancer mortality; malignant neoplasm; public health.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
National ranking with percentage of annual change from 1990 to 2019 in the number of cases (a,b) and deaths (c,d) by cancer group.
Figure 2
Figure 2
Cancer-specific trends from 1990 to 2019 of the age-standardized death rates (per 100,000) in Mexico.
Figure 3
Figure 3
Sex- and age-specific distribution of the incident cases (a) and deaths (b) due to malignant neoplasms in Mexico during 2019, cancer-specific death counts (c), and age-standardized rate of death per 100,000 people by sex (d).
Figure 4
Figure 4
Age-specific rate of death (per 100,000 people) by sex for each group of cancers in Mexico during 2019.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Kocarnik J.M., Compton K., Dean F.E., Fu W., Gaw B.L., Harvey J.D., Henrikson H.J., Lu D., Pennini A., Xu R., et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022;8:420–444. doi: 10.1001/jamaoncol.2021.6987. - DOI - PMC - PubMed
    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Tran K.B., Lang J.J., Compton K., Xu R., Acheson A.R., Henrikson H.J., Kocarnik J.M., Penberthy L., Aali A., Abbas Q. The global burden of cancer attributable to risk factors, 2010–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400:563–591. doi: 10.1016/S0140-6736(22)01438-6. - DOI - PMC - PubMed
    1. Lin L., Li Z., Yan L., Liu Y., Yang H., Li H. Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019. J. Hematol. Oncol. 2021;14:197. doi: 10.1186/s13045-021-01213-z. - DOI - PMC - PubMed

LinkOut - more resources